| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |